Is Ipamorelin FDA Approved?
DrugStatusIndex provides a clear, data-driven view of the regulatory status of medications, compounds, and related products. This page explains whether Ipamorelin is FDA approved and how it is commonly categorized.
Overview
Ipamorelin is a synthetic growth hormone secretagogue peptide commonly marketed for recovery, body composition, anti-aging, and wellness support. It is frequently offered through peptide clinics and research peptide suppliers.
FDA Status Details
Ipamorelin is classified as Not FDA Approved. It has not received FDA approval for prescription use, weight loss treatment, hormone replacement, or general medical use in the United States.
Clinical & Research Status
Ipamorelin remains an investigational peptide and is primarily associated with research use and peptide clinic offerings. There is no FDA-approved branded prescription version available.
Compounding & Safety Considerations
Products marketed as Ipamorelin through peptide clinics or online sellers should not be treated as FDA-approved medications. Quality, dosing consistency, and manufacturing standards may vary significantly.
Search Another Drug or Compound
Use DrugStatusIndex to review public regulatory status information for medications, compounds, and related products.